Barclays corporate bank needs five years to meet RoE target

Barclays will take another five years to reach its corporate bank's return on equity (RoE) target as bad loans in Spain drag on its performance, according to head of the unit John Winter.

Barclays will take another five years to reach its corporate bank's return on equity (RoE) target as bad loans in Spain drag on its performance, according to head of the unit John Winter.

The bank is working to achieve a RoE above its cost of equity, which is 11.5%, by 2015.

However, Winter said the corporate bank is only expected to recover to 8.0% by then and improve by 1.5-2 percentage points a year thereafter.

"No-one's high-fiving each other over 8.0% RoE. But there's a great business here struggling to get out," Winter told Reuters.

Barclays Corporate, which provides services to businesses and financial institutions, has lost £2.1bn on bad loans in Spain in the past three years.

The unit contributes 10% of group revenue but its RoE has been below the bank's cost of equity for years. Last year RoE was just 2.9%.

RoE is a key measure of profitability. It is meant to be at least equal to the cost of equity, the return a bank pays to investors to compensate them for the risk they are taking.

Winter has been trying to turn the unit around since taking charge in 2009 and is shrinking the business in Spain to focus on clients with cross-border needs.

He said the bank had sold two parcels of Spanish loans at a significant discount. But instead of selling further loans at heavily slashed prices, the unit will try to regain value over the longer term, Winter added.

RD

Recommended

Imperial Brands has an 8.3% yield – but what’s the catch?
Share tips

Imperial Brands has an 8.3% yield – but what’s the catch?

Tobacco company Imperial Brands boasts an impressive dividend yield, and the shares look cheap. But investors should beware, says Rupert Hargreaves. H…
20 May 2022
Investing in drugmakers: uncommon profits from curing rare diseases
Share tips

Investing in drugmakers: uncommon profits from curing rare diseases

Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors becaus…
20 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022
Delivering profits: should you buy Royal Mail shares?
Share tips

Delivering profits: should you buy Royal Mail shares?

The volume of parcels delivered by Royal Mail soared during the pandemic, and so did its profits. But it has been coming under pressure lately. So, as…
19 May 2022

Most Popular

The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves looks at the FTSE 100’s top yielding stocks for income investors to consider.
18 May 2022
Aviva: a share for income investors to tuck away
Share tips

Aviva: a share for income investors to tuck away

Insurance giant Aviva is one of the highest yielding stocks in the FTSE 100 – and it’s cheap, too, making it a tempting target for income investors. R…
18 May 2022
Despite the crypto crash, bitcoin still has a bright future
Bitcoin & crypto

Despite the crypto crash, bitcoin still has a bright future

Cryptocurrencies have crashed hard, with bitcoin down by more than 50% from its peak. But, says Dominic Frisby, bitcoin still has a future – it is the…
19 May 2022